Loading clinical trials...
Loading clinical trials...
AWARE: A World-wide Antihistamine-Refractory Chronic Urticaria Patient Evaluation
Conditions
Locations
21
United Kingdom
Novartis Investigative Site
Plymouth, Devon, United Kingdom
Novartis Investigative Site
Darlington, Durham, United Kingdom
Novartis Investigative Site
Leytonstone, London, United Kingdom
Novartis Investigative Site
Salford, Manchester, United Kingdom
Novartis Investigative Site
Coventry, Warwickshire, United Kingdom
Novartis Investigative Site
Belfast, United Kingdom
Start Date
September 3, 2014
Primary Completion Date
September 27, 2017
Completion Date
September 27, 2017
Last Updated
February 15, 2018
NCT04774315
NCT03436797
NCT06063044
NCT04584190
NCT02000648
NCT02047136
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions